It is very rare for Pazdur to make comments on drugs with such praise as he did for ponatinib. The academics know this is a very special drug, so do most doctors in the clinic (ones that a patient would want to be involved with, that is). IMO, this boxed warning is nothing more than semantics and the FDA covering their ass on all angles.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.